CEREBRAL METABOLIC DISTURBANCES IN PATIENTS WITH SUBACUTE AND CHRONIC DIABETES-MELLITUS - DETECTION WITH PROTON MR SPECTROSCOPY

被引:180
|
作者
KREIS, R
ROSS, BD
机构
[1] HUNTINGTON MED RES INST,CLIN MAGNET RESONANCE SPECT LAB,660 S FAIR OAKS AVE,PASADENA,CA 91105
[2] CALTECH,PASADENA,CA 91125
关键词
BRAIN; ABNORMALITIES; MR; DIABETES-MELLITUS; COMPLICATIONS; GLUCOSE; MAGNETIC RESONANCE (MR); SPECTROSCOPY;
D O I
10.1148/radiology.184.1.1319074
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Localized proton magnetic resonance (MR) spectroscopy was used to define biochemical changes in gray and white matter of the cerebral cortex in 22 patients with diabetes mellitus (DM), including 10 episodes of diabetic ketoacidosis (DKA), compared with MR spectra in 30 healthy subjects. Five distinct metabolic abnormalities were identified: Concentrations of glucose (Glc) (P greater-than-or-equal-to .002), ketone body or bodies, myo-inositol (P greater-than-or-equal-to .003) (with or without glycine), and choline (Cho) metabolites were increased in both white and gray matter, whereas a significant reduction of N-acetyl metabolites was found in the parietal cortex (P greater-than-or-equal-to .003). Diurnal variations in the intracerebral concentration of Glc were demonstrated in a patient with DM whose condition was stable. Elevated concentrations of ketones were detected in three episodes and excess Cho in two episodes of DKA. Evidence obtained with hydrogen-1 MR spectroscopy favors acetone rather than acetoacetate as the ketone present in the brain, which is a major target of biochemical change in DM.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 34 条
  • [21] APOLIPOPROTEIN(A) LEVELS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS ARE UNRELATED TO METABOLIC CONTROL OR VASCULAR-DISEASE
    KNOBL, P
    PIETSCHMANN, P
    SCHNACK, C
    PRAGER, R
    SCHERNTHANER, G
    WIENER KLINISCHE WOCHENSCHRIFT, 1994, 106 (23) : 728 - 732
  • [22] CPAP therapy for obstructive sleep apnea syndrome in patients with carbohydrate metabolic disturbances and type 2 diabetes mellitus
    Oleinikov, V. E.
    Sergatskaya, N. V.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (11) : 94 - U113
  • [23] Lifestyle, metabolic compensation in patients with type 2 diabetes mellitus and the risk of chronic disease complications
    Kolpa, Malgorzata
    Grochowska, Aneta
    Kubik, Barbara
    Stradomska, Katarzyna
    CLINICAL DIABETOLOGY, 2018, 7 (03): : 151 - 158
  • [24] VASCULAR-RESPONSE TO VASOACTIVE AGENTS IN DIALYZED PATIENTS WITH CHRONIC-RENAL-FAILURE WITH AND WITHOUT DIABETES-MELLITUS
    NISHI, K
    YOSHIDA, M
    WADA, Y
    KITANI, K
    IKEDA, K
    KAWANO, T
    MACHIDA, J
    MATSUSHITA, K
    CHEN, Y
    UEDA, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (01) : 10 - 15
  • [25] DYNAMICS OF CEREBRAL METABOLISM IN PATIENTS WITH CHRONIC SUBDURAL-HEMATOMA EVALUATED WITH PHOSPHORUS-31 MR SPECTROSCOPY BEFORE AND AFTER SURGERY
    YOSHIDA, K
    FURUSE, M
    IZAWA, A
    IIZIMA, N
    HIRANO, T
    KUCHIWAKI, H
    INAO, S
    SUGITA, K
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1994, 15 (09) : 1681 - 1686
  • [26] IMPROVED METABOLIC CONTROL IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS IS ASSOCIATED WITH A SLOWER ACCUMULATION OF GLYCATION PRODUCTS IN COLLAGEN
    SALMELA, PI
    OIKARINEN, AI
    UKKOLA, O
    KARJALAINEN, A
    LINNALUOTO, M
    PUUKKA, R
    RYHANEN, L
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (07) : 494 - 500
  • [27] Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS: Evidence from proton MR spectroscopy and arterial spin labeling
    Wang, Rong
    Hu, Bin
    Sun, Chong
    Geng, Daoying
    Lin, Jie
    Li, Yuxin
    MITOCHONDRION, 2021, 59 : 276 - 282
  • [28] Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy
    Sinha S.
    Ekka M.
    Sharma U.
    P R.
    Pandey R.M.
    Jagannathan N.R.
    BMC Research Notes, 7 (1)
  • [29] The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting
    Alkaff, Firas Farisi
    Illavi, Fauzan
    Salamah, Sovia
    Setiyawati, Wiwit
    Ramadhani, Ristra
    Purwantini, Elly
    Tahapary, Dicky L.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2021, 12
  • [30] THE DIURETIC-NATRIURETIC EFFICACY OF HUMAN ATRIAL NATRIURETIC PEPTIDE-(95-126) (URODILATIN) IN PATIENTS WITH TYPE-I DIABETES-MELLITUS - DEPENDENCE ON METABOLIC CONTROL
    JUNGMANN, E
    GALETTE, A
    HOPFENMULLER, B
    ZEUZEM, S
    SCHERBERICH, J
    USADEL, KH
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1992, 21 (11) : 695 - 697